TAT 2015 will be held in Paris, France, March 2-4, 2015, under the chairmanship of Professor Jean-Charles Soria, Gustave Roussy Cancer Institute, Villejuif, France.
TAT 2015 will be organized according to the proven standards, developed in the course of the twelve previous TAT Congresses. TAT 2015 will therefore offer the latest on new molecular en immunological targets and agents for innovative cancer therapies, in particular the most promising ones in early-phase clinical development in a confined setting with only plenary sessions. Owing to its medium size, TAT 2015 offers excellent opportunities for networking with the world’s leaders in oncology phase 1 studies from academia and industry.
The provisional scientific agenda and the first list of confirmed faculty are now online. Both will be updated from time to time in late summer / early fall 2014.
Abstract submission for TAT 2015 is now open and will remain open until December 31, CET.